US Agriculture Secretary Ann Veneman has indicated her department is about to get tough on the planting of GM crops designed for use in pharmaceuticals.


Veneman’s words came yesterday [Wednesday] amidst calls for stricter regulations, just weeks after some half a million soybean bushels were put into quarantine after it emerged they had been cultivated on land used the previous season to grow GM corn for ProdiGene, and that some of that corn had been found in the soybeans.


Speaking at the Seventh Annual Farm Journal Forum, Veneman said: “We are proposing additional restrictions.” She went on to pledge to make licensing provisions more rigorous, and to tighten up monitoring activities, reported Dow Jones.


Speculation about the nature of the new restriction was heightened when the USDA and FDA circulated a ‘draft guidance’ document in September. This document indicated that companies wishing to cultivate GM pharmaceutical plants may require a permit from APHIS/BRS, and outlined the role of the producer in guaranteeing the condition of the fields over subsequent seasons. Comment from stakeholder groups was invited.


ProdiGene is expected to receive heavy penalties from the USDA over the soybean contamination incident.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.